Cargando…

High-resolution 3D visualization of nanomedicine distribution in tumors

To improve the clinical translation of anti-cancer nanomedicines, it is necessary to begin building specific insights into the broad concept of the Enhanced Permeability and Retention (EPR) effect, using detailed investigations of the accumulation, distribution and retention of nanomedicines in soli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moss, Jennifer I., Barjat, Hervé, Emmas, Sally-Ann, Strittmatter, Nicole, Maynard, Juliana, Goodwin, Richard J. A., Storm, Gert, Lammers, Twan, Puri, Sanyogitta, Ashford, Marianne B., Barry, Simon T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929971/ https://www.ncbi.nlm.nih.gov/pubmed/31903157 http://dx.doi.org/10.7150/thno.37178

Ejemplares similares

Nanomedicine formulations for combination therapies
por: Lammers, Twan, et al.
Publicado: (2010)

The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor
por: Maynard, Juliana, et al.
Publicado: (2016)

Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution
por: Strittmatter, Nicole, et al.
Publicado: (2022)

The use of (18)F-Fluoro-deoxy-glucose positron emission tomography ((18)F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active dose of AZD8835, a novel PI3Kα inhibitor
por: Maynard, Juliana, et al.
Publicado: (2017)

Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020)

Cancer nanomedicine
por: Bhatia, Sangeeta N., et al.
Publicado: (2022)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Tumour-targeted nanomedicines: principles and practice
por: Lammers, T, et al.
Publicado: (2008)

Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
por: Man, Francis, et al.
Publicado: (2018)

Nanomedicine Strategies to Target Tumor-Associated Macrophages
por: Binnemars-Postma, Karin, et al.
Publicado: (2017)

The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
por: Shi, Yang, et al.
Publicado: (2020)

Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation
por: May, Jan-Niklas, et al.
Publicado: (2020)

Super-resolution Microscopy for Nanomedicine Research
por: Pujals, Silvia, et al.
Publicado: (2019)

Microfluidic-assisted preparation of RGD-decorated nanoparticles: exploring integrin-facilitated uptake in cancer cell lines
por: Rios De La Rosa, Julio M., et al.
Publicado: (2020)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
por: Lammers, T, et al.
Publicado: (2008)

A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
por: Crielaard, Bart J, et al.
Publicado: (2011)

Tackling the challenges of nanomedicines: are we ready?
por: Hertig, John B, et al.
Publicado: (2021)

Nanomedicine
por: Howard, Kenneth A, et al.
Publicado: (2016)

Shelf-Life Evaluation and Lyophilization of PBCA-Based Polymeric Microbubbles
por: Ojha, Tarun, et al.
Publicado: (2019)

Mapping of the available standards against the regulatory needs for nanomedicines
por: Halamoda‐Kenzaoui, Blanka, et al.
Publicado: (2018)

Editorial: Nanomedicine for Deep-Tissue High-Resolution Bio-Imaging and Non-invasive Therapy
por: Gao, Yu, et al.
Publicado: (2020)

Bridging communities in the field of nanomedicine
por: Halamoda-Kenzaoui, Blanka, et al.
Publicado: (2019)

The handbook of nanomedicine
por: Jain, Kewal K
Publicado: (2017)

Principles of nanomedicine
por: Bhattacharjee, Sourav
Publicado: (2019)

The era of nanomedicine
por: Grenha, Ana
Publicado: (2011)

Bionanotechnology and Nanomedicine
por: Chase, P. Bryant, et al.
Publicado: (2012)

Handbook of nanomedicine
por: Jain, Kewal K
Publicado: (2012)

Fucoidans in Nanomedicine
por: Chollet, Lucas, et al.
Publicado: (2016)

Introduction to Nanomedicine
por: Astruc, Didier
Publicado: (2015)

Cancer Nanomedicine
por: Hoskins, Clare
Publicado: (2020)

The consolidation of nanomedicine
por: Zingg, Raphael, et al.
Publicado: (2019)

Heterojunction Nanomedicine
por: Pan, Chao, et al.
Publicado: (2022)

Ocular Nanomedicine
por: Tang, Zhimin, et al.
Publicado: (2022)

BioShuttle Mobility in Living Cells Studied with High-Resolution FCS & CLSM Methodologies
por: Braun, Klaus, et al.
Publicado: (2012)

Advancements in nanomedicines for the detection and treatment of diabetic kidney disease
por: Tillman, Luke, et al.
Publicado: (2022)

Strategies for Cancer Treatment Based on Photonic Nanomedicine
por: de Oliveira, Sueli Aparecida, et al.
Publicado: (2021)

The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles
por: Frigaard, Julie, et al.
Publicado: (2022)

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine
por: Hagan, C. Tilden, et al.
Publicado: (2020)

Using Stock-Flow Diagrams to Visualize Theranostic Approaches to Solid Tumors in Personalized Nanomedicine
por: Cazzagon, Virginia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u3pa2r3nank3gu9fptmugvejlp